Innoviva (INVA) Change in Inventory (2012 - 2026)
Innoviva posted quarterly Change in Inventory of $1.3 million for Q1 2026, down 85.69% year-on-year from $9.2 million in Q1 2025, and down 87.28% on a QoQ basis from $10.3 million in Q3 2025.
Innoviva (INVA) has 8 years of Change in Inventory data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 85.69% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $28.8 million (up 37.02% YoY), and the FY2025 full-year result was $12.9 million, up 89.76% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.3 million, down from $10.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at $10.3 million in Q3 2025 and bottomed at -$350000.0 in Q3 2022.
- The 5-year median for Change in Inventory is $3.8 million (2023), against an average of $4.4 million.
- The widest annual swing landed in 2023, when Change in Inventory surged 1184.86%; it then tumbled 85.69% in 2026.
- A 5-year view of Change in Inventory shows it stood at -$350000.0 in 2022, then soared by 1184.86% to $3.8 million in 2023, then surged by 47.48% to $5.6 million in 2024, then jumped by 83.91% to $10.3 million in 2025, then tumbled by 87.28% to $1.3 million in 2026.
- The last three Change in Inventory figures came in at $1.3 million (Q1 2026), $10.3 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 7.99 Mn |
| Mar 31, 2025 | 9.15 Mn |
| Mar 31, 2025 | 9.15 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 3.54 Mn |
| Mar 31, 2024 | 3.54 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 598,000.00 |
| Mar 31, 2023 | 598,000.00 |
| Sep 30, 2022 | -350,000.00 |
| Sep 30, 2022 | -350,000.00 |
| Jun 30, 2014 | 1.48 Mn |
| Jun 30, 2014 | 1.48 Mn |
| Mar 31, 2014 | 430,000.00 |
| Mar 31, 2014 | 430,000.00 |
| Dec 31, 2013 | 188,000.00 |
| Dec 31, 2013 | 188,000.00 |
| Sep 30, 2013 | 379,000.00 |
| Sep 30, 2013 | 379,000.00 |
| Jun 30, 2013 | 52,000.00 |
| Jun 30, 2013 | 52,000.00 |
| Mar 31, 2013 | 2.48 Mn |
| Mar 31, 2013 | 2.48 Mn |
| Dec 31, 2012 | 255,000.00 |
| Dec 31, 2012 | 255,000.00 |
| Sep 30, 2012 | 268,000.00 |
| Sep 30, 2012 | 268,000.00 |